Eurofins to buy diagnostic PCR specialist for $50m

By Gareth Macdonald contact

- Last updated on GMT

PCR goes made, or at least is increasingly popular among drug firms: Eurofins to buy Diatherix
PCR goes made, or at least is increasingly popular among drug firms: Eurofins to buy Diatherix

Related tags: Health care provider, Pharmacology

Eurofins Scientific has agreed to buy diagnostic testing services firm Diatherix Laboratories for $50m (EUR55m).

The deal, which is expected to complete this month, will bring with it Diatherix’ capabilities in DNA and RNA testing, which are used by 7,000 healthcare professionals for diagnostics and sample analysis.

Eurofins CEO Gilles Martin said: “Diatherix strengthens Eurofins’ growing footprint in the specialty clinical diagnostics market, with truly unique and innovative services with high positive impact for patient care.

Biopharma focus

News of the deal comes just over a year after Eurofins bought ViraCor-IBT Laboratories, a specialist in biomarker analysis for hospitals and biopharmaceutical companies and is part of the same expansion strategy according to Martin.

This acquisition reflects our strategy of expanding and strengthening our network of competence centers. In combination with ViraCor and Boston Heart, Diatherix reinforces the Group’s position in genetic testing to better serve the global healthcare community​.”

It also follows two months after Eurofins' bioanalytical services arm launched an immunoassay service​ for biopharma developers.

Pall​ and Selvita​ have also recently invested in their bioassay platforms for large molecule drug development services.  

Bio-outsourcing is on the rise, reports show,​ with analytical testing – such as assays – topping the list of tasks pharma companies and healthcare providers are willing to send out of house.

Related news

Show more

Related products

show more

QPS: Global Custom-Built Research Services

QPS: Global Custom-Built Research Services

QPS | 16-Dec-2019 | Product Brochure

Performing complex studies in special populations with remarkable agility. Clinical research just got better with QPS’ Custom-Built Research Services....

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Related suppliers

Follow us


View more